Adventris Pharmaceuticals
Adventris makes cancer vaccines
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
- Website
- adventris.com
- City
- Baltimore
- Country
- United States
- YC batch
- Winter 2023
- Team
- 7 people
- Stage
- Early stage
- AI-native
- No
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Baltimore
Claim this profile
Free and instant: prove you run adventris.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Adventris Pharmaceuticals across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Adventris Pharmaceuticals's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
